Condition 1: obesity. Condition 2: overweight. Obesity due to excess calories Obesity, unspecified
Conditions
Interventions
Intervention 1: Patients in the control group receive oral placebo which are specifically designed to have no real effect. They are made of lactose.These pearls in terms of size, shape, packaging an
Treatment - Drugs
Patients in the control group receive oral placebo which are specifically designed to have no real effect. They are made of lactose.These pearls in terms of size, shape, packaging and name are exact
Oral vitamin D supplement ( pearl ) 2000 IU/ d ( = 50 µg/d as cholecalciferol ) will be given to the intervention group until 3 months. Each pearl contains 50000 IU vitamin D3. One pearl will be given
Sponsors
Vice chancellor for research Lorestan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age of 18-70 and BMI>25 Exclusion criteria: to have history of vitamin D deficiency,diabetes mellitus,thyroid disorders, hyperlipidemia,cardiac diseases and use of vitamins and mineral supplements.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body Mass Index (BMI). Timepoint: before intervention and 3 months after study. Method of measurement: balance-meter.;Waist to Hip ratio (W/H). Timepoint: before intervention and 3 months after study. Method of measurement: meter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol. Timepoint: before intervention and 3 months after study. Method of measurement: spectrophotometer.;Triglyceride. Timepoint: before intervention and 3 months after study. Method of measurement: spectrophotometer.;Low density lipoprotein ( LDL). Timepoint: Before intervention and 3 months after study. Method of measurement: Spectrophotometer.;High density lipoprotein (HDL). Timepoint: before intervention and 3 months after study. Method of measurement: spectrophotometer.;Serum 25 hydroxyvitamin D. Timepoint: Before intervention and 3 months after study. Method of measurement: IBL company laboratory kit.;Serum calcium. Timepoint: Before intervention and 3 months after study. Method of measurement: Spectrophotometer.;Serum phosphorus. Timepoint: Before intervention and 3 months after study. Method of measurement: spectrophotometer.;Parathyroid hormone (PTH). Timepoint: Before intervention and 3 months after study. Method of measurement: ELISA.;Received energy. Timepoint: 3 days during the intervention. Method of measurement: Questionnaire and N4 software.;Received calcium. Timepoint: 3 days during the intervention. Method of measurement: Questionnaire and N4 software.;Received phosphorus. Timepoint: 3 days during the intervention. Method of measurement: Questionnaire and N4 software.;Received vitamin D. Timepoint: 3 days during the intervention. Method of measurement: Questionnaire and N4 software.;Received nutrient elements. Timepoint: 3 days during the intervention. Method of measurement: Questionnaire and N4 software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Hasan Kayedi
Vice chancellor for research and technology of Lorestan University Of Medical Sciences
Outcome results
None listed